PHE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cipher Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 10.5 EUR 6.06% Market Closed

Market Cap: €268.7m

C	Cipher Pharmaceuticals Inc F:PHE	CA
R	Ratch Group PCL SET:RATCH	TH
	DBS Group Holdings Ltd F:DEV	SG
S	StreaksAI PLC F:NM1	UK
B	Boeing Co F:BCO	US
G	Gap Inc XMUN:GAP	US
T	Tenaris SA LSE:0HXB	LU

Profitability Summary

Cipher Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

78%

Declining Gross Margin

81% > 80%

Exceptional Operating Margin

33%

Strong 3Y Average Operating Margin

36%

Declining Operating Margin

47% > 33%

Exceptional Net Margin

54%

Strong 3Y Average Net Margin

75%

Declining Net Margin

141% > 54%

Exceptional Free Cash Flow Margin

59%

Negative 3Y Average Free Cash Flow Margin

-21%

Declining Free Cash Flow Margin

65% > 59%

Positive ROE

24%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

40%

Declining ROIC

72% > 19%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.